SCHEMBL6068249

SCHEMBL6068249

COc1ccccc1C1CCN(C[C@H](N)CC2CCCCC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.55
MEN1 O00255 8/20 0.54
KMT2A Q03164 8/20 0.54
DRD4 P21917 3/20 0.47
GRM2 Q14416 1/20 0.47
ATM Q13315 1/20 0.47
HTR7 P34969 1/20 0.45
MAPK1 P28482 1/20 0.44
HTR2C P28335 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6068218 0.86 DRD2 (0.53) DRD2MEN1KMT2ADRD4GRM2
SCHEMBL6068222 0.84 DRD2 (0.53) DRD2MEN1KMT2ADRD4GRM2
SCHEMBL7155140 0.84 MEN1 (0.54) DRD2MEN1KMT2ADRD4GRM2
SCHEMBL6068330 0.84 MEN1 (0.54) DRD2MEN1KMT2ADRD4GRM2
SCHEMBL6068170 0.81 DRD2 (0.52) DRD2MEN1KMT2A
SCHEMBL12897454 0.81 DRD2 (0.64) DRD2MEN1KMT2ADRD4GRM2
SCHEMBL6179069 0.81 MEN1 (0.67) DRD2MEN1KMT2ADRD4GRM2
SCHEMBL12897166 0.80 DRD2 (0.66) DRD2MEN1KMT2ADRD4GRM2
Hydrochloric Acid SCHEMBL6313945 0.80 RECQL (0.52) DRD2MEN1KMT2A
SCHEMBL6180651 0.78 MEN1 (0.56) DRD2MEN1KMT2ADRD4GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7049330-B2 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents WYETH (US) 2006-05-23 US claimed
US-20030139449-A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents WYETH (US) 2003-07-24 US claimed
US-6518272-B2 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer WYETH 2003-02-11 US claimed
US-20020156075-A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents WYETH (FORMERLY AMERICAN HOME PRODUCTS CORPORATION) (US) 2002-10-24 US claimed
US-7049330-B2 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents WYETH (US) 2006-05-23 US disclosed
US-20030139449-A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents WYETH (US) 2003-07-24 US disclosed
US-6518272-B2 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer WYETH 2003-02-11 US disclosed
US-20020156075-A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents WYETH (FORMERLY AMERICAN HOME PRODUCTS CORPORATION) (US) 2002-10-24 US disclosed
US-6376494-B1 USED IN THE TREATMENT OF ANXIETY AND DEPRESSION AMERICAN HOME PRODUCTS CORPORATION 2002-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139449-A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents HTR5A, MC5R, CHRNA5 DRD2 59/4885MEN1 2716/4885KMT2A 3539/4885
US-20020156075-A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents HTR5A, MC5R, CHRNA5 DRD2 59/4885MEN1 2716/4885KMT2A 3539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.